Center them. Gamalei began preclinical research on a platform for vaccines that could protect against several different viruses or several variants of the same virus at once. This was announced on Saturday, October 16, by the director of the center Alexander Gintsburg.
“This is a vaccine that we have now begun to test in preclinical trials on monkeys. The meaning of this technology is that <...> you can immediately protect [человека] from different strains of the same pathogen or even from different viruses circulating in the human population at the same time “, – quotes Gunzburg TASS…
In particular, we are talking about the possible combination of various antigens of influenza and coronavirus viruses, the head of the center noted.
On October 4, the head of the Russian Ministry of Health, Mikhail Murashko, announced the good results of the first trials of the effectiveness of the joint administration of vaccines against coronavirus and influenza.
According to Alexander Gorelov, deputy director for scientific work of the Central Research Institute of Epidemiology of Rospotrebnadzor, until new recommendations appear between the introduction of vaccines against COVID-19 and influenza, an interval of one month should be observed.
On October 13, Russian Prime Minister Mikhail Mishustin said that almost a third of the country’s population was fully vaccinated against coronavirus. As the head of government specified, the situation is complicated by the season of the spread of influenza, and it is very important “to take the utmost responsibility to your health and not to forget about those around you.”
Large-scale vaccination is ongoing in Russia. The vaccination is given free of charge to everyone. Earlier, five drugs for coronavirus were registered in the country: Sputnik V, which became the first vaccine against COVID-19 in the Russian Federation and the world, Sputnik Light, EpiVacCorona, KoviVak and EpiVacCorona-N.
All relevant information on the situation with the coronavirus is available on the websites stopcoronavirus.rf and access to all.rf, as well as by the hashtag #WeVeTogether. Coronavirus hotline: 8-800-2000-112.